C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/37 (2006.01) G06F 19/00 (2006.01)
Patent
CA 2324379
The present invention relates to in vitro and ex vivo methods of screening for modulators, homologues, and mimetics of lethal factor mitogen activated protein kinase kinase (MAPKK) protease activity, as well as methods of treating cancer by administering LF to transformed cells.
La présente invention concerne des procédés permettant de rechercher systématiquement, in vitro comme ex vivo, des modulateurs, des homologues et des mimétiques de l'activité protéasique de la MAPKK (mitogen activated protein kinase kinase) du facteur létal, c'est-à-dire la kinase de protéine kinase activée par les mitonnes du facteur létal. L'invention concerne également une thérapie anticancéreuse consistant en l'administration de facteur létal à des cellules transformées.
Duesbery Nicholas
Leppla Stephen
Vande Woude George
Webb Craig
Department Of Health And Human Services The Government Of The United States Of America Represented By Th
Fetherstonhaugh & Co.
LandOfFree
Anthrax lethal factor is a mapk kinase protease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anthrax lethal factor is a mapk kinase protease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anthrax lethal factor is a mapk kinase protease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1596116